As mentioned in the last blog post, India has gone one full year without a single polio case, thanks in large part to an army of volunteer vaccinators that fanned o

In 1957, during a time when polio epidemics ravaged countries worldwide and many considered polio to be the world's most feared disease, Albert B. Sabin began human trials to test his live oral polio vaccine. From 1952 to 1961, the number of polio cases in the United States fell from 58,000 to 161, due in large part to Sabin's vaccine.
Albert B Sabin is probably best known for his work and research on the polio virus. During World War II he worked on and developed vaccines for encephalitis (sleeping sickness), sand-fly fever and dengue fever as well. It is his work into dengue fever during this time that is now having possible implications for vaccine development today — 60 years later.

The World Health Organization (WHO) and the Public Library of Science (PLoS) are launching a new initiative to support the latest WHO World Health Report by encouraging authors to submit articles that substantiate the WHO's message, that research is essential for better

Last week in an op-ed for the International Herald Tribune, Steven L. Weinreb, M.D., provided an important lesson about vaccines and immunity.

As reported earlier this week in Voice of America News, the Zimbabwe health ministry is making plans to target typhoid, cholera and other water-borne diseases in t

Last week in separate deals with the GAVI Alliance, the drug companies Pfizer and GlaxoSmithKline (GSK) agreed to increase sales of cut-price pneumonia vaccines by 180 million doses, a 50% increase from previous commitments.

Dr. Ciro de Quadros appointed to Decade of Vaccines (DoV) Collaboration leadership

Today the Decade of Vaccines (DoV) Collaboration announced that Sabin executive vice president Dr. Ciro de Quadros was appointed to the important leadership position of co-chair of the DoV Steering Committee. In line with Sabin's own mission, the purpose of the DoV is to extend the full benefits of immunization to all people, regardless of where they live.

Today the Decade of Vaccines (DoV) Collaboration announced that Sabin executive vice president Dr. Ciro de Quadros was appointed to the important leadership position of co-chair of the DoV Steering Committee. In line with Sabin's own mission, the purpose of the DoV is to extend the full benefits of immunization to all people, regardless of where they live.

Pages